CASTIGLIA, Marta
CASTIGLIA, Marta
Biomedicina, Neuroscienze e Diagnostica avanzata
Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions
2018-01-01 Di Stefano AB, Massihnia D, Grisafi F, Castiglia M, Toia F, Montesano L, Russo A, Moschella F, Cordova A.
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it
2014-01-01 Rolfo, Christian*; Passiglia, Francesco; Castiglia, Marta; Raez, Luis E.; Germonpre, Paul; Gil-Bazo, Ignacio; Zwaenepoel, Karen; De Wilde, Annemieke; Bronte, Giuseppe; Russo, Antonio; Van Meerbeeck, Jan P.; Van Schil, Paul; Pauwels, Patrick
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus
2016-01-01 Cabibi, D.; Caruso, S.; Bazan, V.; Castiglia, M.; Bronte, G.; Ingrao, S.; Fanale, D.; Cangemi, A.; Calò, V.; Listì, A.; Incorvaia, L.; Galvano, A.; Pantuso, G.; Fiorentino, E.; Castorina, S.; Russo, A.
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects
2014-01-01 Bronte, G; Rolfo, C; Giovannetti, E; Cicero, G; Pauwels, P; Passiglia, F; Castiglia, M; Rizzo, S; Lo Vullo, F; Fiorentino, E; Van Meerbeeck, J; Russo, A
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
2016-01-01 Fanale, D.; Amodeo, V.; Bazan, V.; Insalaco, L.; Incorvia L; Barraco, N.; Castiglia, M.; Rizzo, S.; Santini, D.; Giordano, A.; Castorina, S.; Russo, A.
Cancer and the microbiome: Potential applications as new tumor biomarker
2015-01-01 Shahanavaj, K.; Gil-Bazo, I.; Castiglia, M.; Bronte, G.; Passiglia, F.; Carreca, A.; Del Pozo, J.; Russo, A.; Peeters, M.; Rolfo, C.
Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells
2020-01-01 Di Stefano AB, Grisafi F, Perez-Alea M, Castiglia M, Di Simone M, Meraviglia S, Cordova A, Moschella F, Toia F.
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546]
2015-01-01 Rolfo C.; Castiglia M.; Hong D.; Alessandro R.; Mertens I.; Baggerman G.; Zwaenepoel K.; Gil-Bazo I.; Passiglia F.; Carreca A.P.; Taverna S.; Vento R.; Santini D.; Peeters M.; Russo A.; Pauwels P.
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
2018-01-01 Passiglia, Francesco; Rizzo, Sergio; Di Maio, Massimo; Galvano, Antonio; Badalamenti, Giuseppe; Listì, Angela; Gulotta, Leonardo; Castiglia, Marta; Fulfaro, Fabio; Bazan, Viviana; Russo, Antonio
Dietary restriction: could it be considered as speed bump on tumor progression road?
2016-01-01 Cangemi, A.; Fanale, D.; Rinaldi, G.; Bazan, V.; Galvano, A.; Perez, A.; Barraco, N.; Massihnia, D.; Castiglia, M.; Vieni, S.; Bronte, G.; Mirisola, M.; Russo, A.
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE
2010-01-01 Amodeo, V; Insalaco, L; Terrasi, M; Fanale, D; Margarese, N; La Paglia, L; Corsini, L; Napoli, L; Damiani, G; Castiglia, M; Di Piazza, F; Miraglia, M; Bazan, V; Russo, A
EGFR inhibition in NSCLC: New findings…. and opened questions?
2017-01-01 Passiglia, F.; Listì, A.; Castiglia, M.; Perez, A.; Rizzo, S.; Bazan, V.; Russo, A.
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4)
2018-01-01 Passiglia F.; Rizzo S.; Di Maio M.; Galvano A.; Badalamenti G.; Listi A.; Gulotta L.; Castiglia M.; Fulfaro F.; Bazan V.; Russo A.
Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients' plasma through qPCR: A feasible liquid biopsy tool
2016-01-01 Giallombardo, Marco; Borrás, Jorge Chacártegui; Castiglia, Marta; Van Der Steen, Nele; Mertens, Inge; Pauwels, Patrick; Peeters, Marc; Rolfo, Christian
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice
2016-01-01 Taverna, S.; Giallombardo, M.; Gil-Bazo, I.; Carreca, A.; Castiglia, M.; Chacártegui, J.; Araujo, A.; Alessandro, R.; Pauwels, P.; Peeters, M.; Rolfo, C.
A headlight on liquid biopsies: a challenging tool for breast cancer management
2016-01-01 Massihnia, D.; Perez, A.; Bazan, V.; Bronte, G.; Castiglia, M.; Fanale, D.; Barraco, N.; Cangemi, A.; Di Piazza, F.; Calò, V.; Rizzo, S.; Cicero, G.; Pantuso, G.; Russo, A.
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes
2020-01-01 Incorvaia L.; Fanale D.; Badalamenti G.; Bono M.; Calo V.; Cancelliere D.; Castiglia M.; Fiorino A.; Pivetti A.; Barraco N.; Cutaia S.; Russo A.; Bazan V.
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION
Cancelliere D*, Pivetti A*, Barraco N*, Bono M*, Calò V*, Castiglia M*, Cucinella A*, Cutaia S*, Di Piazza F*, Fanale D*, Lisanti M.C*, Listì A*, *, Bazan V.*, Russo A*,
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions
2013-01-01 Fanale, D; Bazan, V; Corsini, L; Caruso, S; Insalaco, L; Castiglia, M; Cicero, G; Bronte, G; Russo, A
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines
2013-01-01 Fanale, D; Bazan, V; Caruso, S; Castiglia, M; Bronte, G; Rolfo, C; Cicero, G; Russo, A